(AUSTIN) – The Cancer Prevention and Research Institute of Texas (CPRIT) announced today the appointment of Tracey B. Davies as Chief Strategic Initiatives and Intellectual Property Officer.
“Ms. Davies’ program development, management and intellectual property expertise as well as her experience working with life science companies creating new therapeutics will be a major asset for CPRIT as we plan for the next decade and accelerate the advancement of IP developed with CPRIT investment,” CPRIT CEO Wayne Roberts said. “We are eager to find new ways to integrate our cancer prevention and research efforts, including with new public/private partnerships promoting Texas’ research and applied science superiority.”
Davies has more than 20 years of experience advising life science companies at all stages of development and research institutions across a broad range of business and legal issues. She is also a licensed patent attorney. Prior to joining CPRIT, she was a partner with Gibson Dunn & Crutcher L.L.P., and co-chaired the firm’s Life Sciences practice as well as serving as a member of the firm’s Intellectual Property and Litigation practice groups. Previously, Davies was a partner and member of the Executive Management Committee at Vinson & Elkins, L.L.P., where she led the firm’s Intellectual Property, Technology and Life Science practices. Davies received her J.D. from the University of Minnesota, where she also earned a master’s degree in Public Health. She begins work at CPRIT on March 1, 2021.
“I am delighted to join CPRIT and to have this outstanding opportunity to help CPRIT shape the next decade of its mission of accelerating breakthroughs in cancer research, prevention and product development,” Davies said. “I look forward to contributing to CPRIT’s already substantial successes in meeting that mission by leveraging the work and intellectual property previously generated to further grow the life science infrastructure of Texas.”
About the Cancer Prevention and Research Institute of Texas
CPRIT has awarded $2.7 billion in grants to Texas research institutions and organizations through its academic research, prevention, and product development research programs. CPRIT has recruited 228 distinguished researchers, supported the establishment, expansion or relocation of 42 companies to Texas, and generated more than $5 billion in additional public and private investment. CPRIT funding has advanced scientific and clinical knowledge and provided 7 million life-saving cancer prevention and early detection services reaching Texans from all 254 counties. On November 5, 2019, Texas voters overwhelmingly approved a constitutional amendment providing an additional $3 billion to CPRIT for a total $6 billion investment in cancer research and prevention efforts across Texas, one of the largest state funded research programs in United States history and the second largest source of funding for cancer research in the world.